Suppr超能文献

使用锁核酸/2'-O-甲基寡核苷酸混合体、肽核酸(PNA)以及PNA-肽缀合物靶向作用于miR-122 。

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.

作者信息

Fabani Martin M, Gait Michael J

机构信息

Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.

出版信息

RNA. 2008 Feb;14(2):336-46. doi: 10.1261/rna.844108. Epub 2007 Dec 11.

Abstract

MicroRNAs are small noncoding RNAs that regulate many cellular processes in a post-transcriptional mode. MicroRNA knockdown by antisense oligonucleotides is a useful strategy to explore microRNA functionality and as potential therapeutics. MicroRNA-122 (miR-122) is a liver-specific microRNA, the main function of which has been linked with lipid metabolism and liver homeostasis. Here, we show that lipofection of an antisense oligonucleotide based on a Locked Nucleic Acids (LNA)/2'-O-methyl mixmer or electroporation of a Peptide Nucleic Acid (PNA) oligomer is effective at blocking miR-122 activity in human and rat liver cells. These oligonucleotide analogs, evaluated for the first time in microRNA inhibition, are more effective than standard 2'-O-methyl oligonucleotides in binding and inhibiting microRNA action. We also show that microRNA inhibition can be achieved without the need for transfection or electroporation of the human or rat cell lines, by conjugation of an antisense PNA to the cell-penetrating peptide R6-Penetratin, or merely by linkage to just four Lys residues, highlighting the potential of PNA for future therapeutic applications as well as for studying microRNA function.

摘要

微小RNA是一类小的非编码RNA,它们以转录后方式调控许多细胞过程。通过反义寡核苷酸敲低微小RNA是探索微小RNA功能以及作为潜在治疗手段的一种有用策略。微小RNA-122(miR-122)是一种肝脏特异性微小RNA,其主要功能与脂质代谢和肝脏稳态相关。在此,我们表明基于锁核酸(LNA)/2'-O-甲基混合寡聚物的反义寡核苷酸的脂质体转染或肽核酸(PNA)寡聚物的电穿孔在阻断人和大鼠肝细胞中的miR-122活性方面是有效的。这些首次在微小RNA抑制中评估的寡核苷酸类似物在结合和抑制微小RNA作用方面比标准的2'-O-甲基寡核苷酸更有效。我们还表明,通过将反义PNA与细胞穿透肽R6-穿膜肽偶联,或者仅仅与四个赖氨酸残基连接,无需对人或大鼠细胞系进行转染或电穿孔就能实现微小RNA抑制,这突出了PNA在未来治疗应用以及研究微小RNA功能方面的潜力。

相似文献

4
A short phosphodiester window is sufficient to direct RNase H-dependent RNA cleavage by antisense peptide nucleic acid.
Antisense Nucleic Acid Drug Dev. 2000 Dec;10(6):463-8. doi: 10.1089/oli.1.2000.10.463.
9
A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.
Mol Cells. 2009 Oct 31;28(4):341-5. doi: 10.1007/s10059-009-0134-8. Epub 2009 Sep 30.
10
Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids.
Mol Pharmacol. 2000 Apr;57(4):725-31. doi: 10.1124/mol.57.4.725.

引用本文的文献

1
Enhancing RNA inhibitory activity using clamp-G-modified nucleobases.
Cell Rep Phys Sci. 2024 Aug 21;5(8). doi: 10.1016/j.xcrp.2024.102120. Epub 2024 Jul 29.
2
Oligonucleotide therapies for nonalcoholic steatohepatitis.
Mol Ther Nucleic Acids. 2024 Mar 30;35(2):102184. doi: 10.1016/j.omtn.2024.102184. eCollection 2024 Jun 11.
3
An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction.
NAR Genom Bioinform. 2024 Feb 24;6(1):lqae022. doi: 10.1093/nargab/lqae022. eCollection 2024 Mar.
4
Antisense Therapy for Infectious Diseases.
Cells. 2023 Aug 21;12(16):2119. doi: 10.3390/cells12162119.
5
Recent Development in Biomedical Applications of Oligonucleotides with Triplex-Forming Ability.
Polymers (Basel). 2023 Feb 9;15(4):858. doi: 10.3390/polym15040858.
6
Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
RNA. 2023 Apr;29(4):434-445. doi: 10.1261/rna.079498.122. Epub 2023 Jan 18.
7
Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target.
Mol Cell Oncol. 2022 Oct 24;9(1):2136476. doi: 10.1080/23723556.2022.2136476. eCollection 2022.
10
Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases.
Futur J Pharm Sci. 2022;8(1):24. doi: 10.1186/s43094-022-00413-9. Epub 2022 Apr 1.

本文引用的文献

1
Disulfide conjugation of peptides to oligonucleotides and their analogs.
Curr Protoc Nucleic Acid Chem. 2006 Apr;Chapter 4:Unit 4.28. doi: 10.1002/0471142700.nc0428s24.
2
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.
Nat Methods. 2007 Sep;4(9):721-6. doi: 10.1038/nmeth1079. Epub 2007 Aug 12.
5
Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.
Nucleic Acids Res. 2007;35(13):4495-502. doi: 10.1093/nar/gkm418. Epub 2007 Jun 21.
6
Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse.
Mol Ther. 2007 Sep;15(9):1587-92. doi: 10.1038/sj.mt.6300245. Epub 2007 Jun 19.
7
Specificity, duplex degradation and subcellular localization of antagomirs.
Nucleic Acids Res. 2007;35(9):2885-92. doi: 10.1093/nar/gkm024. Epub 2007 Apr 16.
8
Distance constraints between microRNA target sites dictate efficacy and cooperativity.
Nucleic Acids Res. 2007;35(7):2333-42. doi: 10.1093/nar/gkm133. Epub 2007 Mar 27.
9
Stress-induced reversal of microRNA repression and mRNA P-body localization in human cells.
Cold Spring Harb Symp Quant Biol. 2006;71:513-21. doi: 10.1101/sqb.2006.71.038.
10
Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
Cold Spring Harb Symp Quant Biol. 2006;71:369-76. doi: 10.1101/sqb.2006.71.022.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验